PEGylated drugs in rheumatology--why develop them and do they work?
about
Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivoInduced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipientsCompstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.Harnessing nanoparticles for immune modulationPeptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.Management of rheumatoid arthritis: Impact and risks of various therapeutic approachesEfficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritisPEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
P2860
Q30300201-FB1E0E03-9BD7-42EE-B360-590CDB313C81Q33766720-FB05969D-6811-4EB3-B73F-F6F38C5E819AQ35236103-4441EFC5-45D4-4E50-B6EE-575010B9A8E5Q35252156-CF0F5E19-B5A1-4041-A87E-2DA123678CD6Q36154772-6BB3DE0F-947C-4518-B674-EC244C2DBF20Q37670073-BBA7F03B-298E-4EF9-A120-9FBB4D73658CQ38208275-7B5BA69E-C902-47D5-BB31-CADAAC73DD56Q39646028-F8334332-3EDE-4EC0-9014-B09F82A2B197Q57330038-F185245E-7C42-4A1C-B033-014CD126E8E2Q58580417-4973EB5C-2134-4E27-AF73-41878782C708
P2860
PEGylated drugs in rheumatology--why develop them and do they work?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PEGylated drugs in rheumatology--why develop them and do they work?
@en
type
label
PEGylated drugs in rheumatology--why develop them and do they work?
@en
prefLabel
PEGylated drugs in rheumatology--why develop them and do they work?
@en
P2093
P2860
P921
P356
P1433
P1476
PEGylated drugs in rheumatology--why develop them and do they work?
@en
P2093
Anisur Rahman
Thomas McDonnell
Yiannis Ioannou
P2860
P304
P356
10.1093/RHEUMATOLOGY/KET278
P577
2013-08-20T00:00:00Z
2014-03-01T00:00:00Z